Abstract 3145: Smyd3 catalyzes a novel methylation mark and regulates cancer cell proliferation
Glenn S. VanAller(GlaxoSmithKline (United States)), Ryan G. Kruger(Arysta LifeScience (France)), Ben Garcia(University of Pennsylvania), Nicolas Reynoird(Centre National de la Recherche Scientifique), Michael J. Huddleston(GlaxoSmithKline (United States)), Peter J. Tummino(Intarcia Therapeutics (United States)), Or Gozani(Stanford University), BaoChau Le(GlaxoSmithKline (United States)), Olena Barbash(GlaxoSmithKline (United States)), Roland S. Annan(GlaxoSmithKline (United Kingdom))
Cited by 1
Related Papers
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848